Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Preisser

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
The Prostate|February 21, 2018
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasionFelix Preisser, Marco Bandini, Michele Marchioni, et al.
Clinical Genitourinary Cancer|April 22, 2019
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial CarcinomaSebastiano Nazzani, Felix Preisser, Elio Mazzone, et al.
European Urology Oncology|August 15, 2019
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade GroupsFelix Preisser, Marco Bandini, Sebastiano Nazzani, et al.
European Urology Focus|May 27, 2018
Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results databaseFelix Preisser, Marco Bandini, Elio Mazzone, et al.
Prostate Cancer and Prostatic Diseases|January 18, 2018
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based studyRaisa S Pompe, Ariane Smith, Marco Bandini, et al.
Current Urology|November 23, 2023
Comparison of survival outcomes between laparoscopic versus open radical nephroureterectomy in upper tract urothelial cancer patients: Experiences of a tertiary care single centerBenedikt Hoeh, Marina Kosiba, Mike Wenzel, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate CancerClara Humke, Benedikt Hoeh, Felix Preisser, et al.
The Prostate|April 18, 2018
Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substagesRaisa S Pompe, Derya Tilki, Felix Preisser, et al.
Frontiers in Oncology|August 16, 2021
Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical ProstatectomyPhilipp Mandel, Benedikt Hoeh, Felix Preisser, et al.
Cancers|February 13, 2025
Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal TherapyFabian Falkenbach, Johanna Hagemann, Francesca Ambrosini, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
The Prostate|February 21, 2018
Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasionFelix Preisser, Marco Bandini, Michele Marchioni, et al.
Clinical Genitourinary Cancer|April 22, 2019
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial CarcinomaSebastiano Nazzani, Felix Preisser, Elio Mazzone, et al.
European Urology Oncology|August 15, 2019
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade GroupsFelix Preisser, Marco Bandini, Sebastiano Nazzani, et al.
European Urology Focus|May 27, 2018
Validation of the Social Security Administration Life Tables (2004-2014) in Localized Prostate Cancer Patients within the Surveillance, Epidemiology, and End Results databaseFelix Preisser, Marco Bandini, Elio Mazzone, et al.
Prostate Cancer and Prostatic Diseases|January 18, 2018
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based studyRaisa S Pompe, Ariane Smith, Marco Bandini, et al.
Current Urology|November 23, 2023
Comparison of survival outcomes between laparoscopic versus open radical nephroureterectomy in upper tract urothelial cancer patients: Experiences of a tertiary care single centerBenedikt Hoeh, Marina Kosiba, Mike Wenzel, et al.
Current Oncology (Toronto, Ont.)|April 21, 2022
Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate CancerClara Humke, Benedikt Hoeh, Felix Preisser, et al.
The Prostate|April 18, 2018
Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substagesRaisa S Pompe, Derya Tilki, Felix Preisser, et al.
Frontiers in Oncology|August 16, 2021
Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical ProstatectomyPhilipp Mandel, Benedikt Hoeh, Felix Preisser, et al.
Cancers|February 13, 2025
Patient-Reported Outcome Measures and Decision Regret After Salvage Radical Prostatectomy for Recurrent Prostate Cancer Following Radiotherapy or Focal TherapyFabian Falkenbach, Johanna Hagemann, Francesca Ambrosini, et al.
Pageof 17